MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$27,278K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Reserve for claims and performan...
Depreciation and amortization ex...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Accounts receivable, net and con...
Loss before preferred dividends ...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Loss before preferred dividends and accretion of series a preferred stock
-28,364
-26,632
-429,131
-20,864
Change in fair value of contingent consideration
0
0
4,658
-1,089
(gain) loss on disposal of non-strategic assets
-
-
14,867
-
Loss (gain) from equity method investees
-41
-11
31
156
Extinguishment of series a preferred stock and other refinancing fees
0
-
0
6,000
Gain on extinguishment of short-term debt
-
-
-
431
Loss on option exercise
0
0
0
0
Depreciation and amortization expenses
21,566
21,555
45,037
23,615
Stock-based compensation expense
15,201
10,649
2,396
14,682
Deferred tax expense
2,393
577
-3,039
627
Amortization of contract cost assets
1,092
931
1,090
3,181
Amortization of deferred financing costs
2,981
2,949
3,042
2,359
Goodwill impairment
-
-
398,000
-
Loss on extinguishment/repayment of debt, net
-
-
-3,483
-
Right-of-use asset impairment
-
-
0
-
Loss on lease termination
0
0
0
1,230
Change in tax receivables agreement liability
-
-
-804
0
Right-of-use operating assets
-1,156
-507
-464
-505
Other current operating cash inflows (outflows), net
-
0
0
0
Accounts receivable, net and contract assets
134,960
4,297
-66,339
48,561
Prepaid expenses and other current and non-current assets
659
3,372
-4,600
-2,191
Contract cost assets
1,408
1,125
3,467
1,837
Accounts payable
-23,198
5,388
-14,862
3,312
Accrued liabilities
-1,368
-20,982
7,356
1,468
Operating lease liabilities
-7,972
-7,222
-3,214
-9,014
Accrued compensation and employee benefits
-2,041
-19,980
-4,393
17,118
Deferred revenue
-209
214
-668
-462
Reserve for claims and performance-based arrangements
146,436
39,766
-19,456
24,401
Other long-term liabilities
1
79
4,228
-3
Net cash and restricted cash used in operating activities
-9,312
-984
48,800
15,812
Cash paid for asset acquisitions and business combinations
0
0
1,398
-2
Proceeds from disposal of non-strategic assets
-
-
91,312
-
Return of equity method investments
150
-
0
198
Purchases of investments and contributions to equity method investees
0
-
0
0
Investments in internal-use software and purchases of property and equipment
6,849
6,406
7,761
8,962
Net cash and restricted cash used in investing activities
-6,699
-6,406
82,153
-8,762
Changes in working capital balances related to claims processing
986
2,157
-2,444
578
Payment of contingent consideration
0
-
0
750
Proceeds from stock option exercises
-
-
0
0
Proceeds from issuance of preferred stock, net of offering costs
-
-
0
-
Proceeds from issuance of long-term debt, net of offering costs
0
0
-18,307
-168,740
Repayment of long-term debt
-
-
-
166,755
Repayment of debt
10,000
0
342,984
-
Repurchase of common stock
-
-
0
39,996
Payment of preferred dividends
0
0
0
1,929
Taxes withheld and paid for vesting of equity awards
7
1,816
58
547
Net cash and restricted cash (used in) provided by financing activities
-10,993
-3,973
-93,036
-41,815
Effect of exchange rate on cash and cash equivalents and restricted cash
-274
-589
-225
-201
Net decrease in cash and cash equivalents and restricted cash
-27,278
-11,952
37,692
-34,966
Cash and cash equivalents and restricted cash as of beginning-of-period
168,744
180,696
143,004
178,496
Cash and cash equivalents and restricted cash as of end-of-period
141,466
168,744
180,696
143,004
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$27,278K
(-5085.93%↓ Y/Y)
Reserve for claims and
performance-based arrangements
$146,436K
(211.40%↑ Y/Y)
Depreciation and
amortization expenses
$21,566K
(-54.31%↓ Y/Y)
Stock-based compensation
expense
$15,201K
(-32.92%↓ Y/Y)
Amortization of deferred
financing costs
$2,981K
(24.05%↑ Y/Y)
Deferred tax expense
$2,393K
(519.82%↑ Y/Y)
Right-of-use operating
assets
-$1,156K
(-45.96%↓ Y/Y)
Amortization of contract cost
assets
$1,092K
(-56.72%↓ Y/Y)
Loss (gain) from
equity method...
-$41K
(-123.03%↓ Y/Y)
Other long-term
liabilities
$1K
(-99.88%↓ Y/Y)
Return of equity method
investments
$150K
(-80.96%↓ Y/Y)
Net cash and
restricted cash (used in)...
-$10,993K
(-111.11%↓ Y/Y)
Net cash and
restricted cash used in...
-$9,312K
(63.86%↑ Y/Y)
Net cash and
restricted cash used in...
-$6,699K
(90.90%↑ Y/Y)
Effect of exchange rate
on cash and cash...
-$274K
(-356.67%↓ Y/Y)
Canceled cashflow
$190,867K
Canceled cashflow
$150K
Repayment of debt
$10,000K
Changes in working
capital balances...
$986K
(-97.80%↓ Y/Y)
Taxes withheld and
paid for vesting of...
$7K
(-99.85%↓ Y/Y)
Accounts receivable, net
and contract assets
$134,960K
(341.32%↑ Y/Y)
Investments in internal-use
software and purchases of...
$6,849K
(-60.56%↓ Y/Y)
Loss before
preferred dividends and...
-$28,364K
(66.44%↑ Y/Y)
Accounts payable
-$23,198K
(-227.54%↓ Y/Y)
Operating lease
liabilities
-$7,972K
(61.99%↑ Y/Y)
Accrued compensation
and employee...
-$2,041K
(-144.93%↓ Y/Y)
Contract cost assets
$1,408K
(-14.61%↓ Y/Y)
Accrued liabilities
-$1,368K
(76.68%↑ Y/Y)
Prepaid expenses and
other current and...
$659K
(-63.45%↓ Y/Y)
Deferred revenue
-$209K
(-20.11%↓ Y/Y)
Buy us a coffee
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)